Retour
Fourchette du Jour
22,48 €
23,67 €
Fourchette 52 Semaines
13,36 €
27,55 €
Volume
118 556
Moyenne 50J / 200J
23,15 €
/
19,54 €
Clôture Précédente
23,67 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,4 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
33,33 €
+42.6%
Low: 31,00 €
High: 35,00 €
BPA Prévisionnel
-4,05 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
-4,59 €
-6,12 € – -3,05 €
|
0 | 2 |
| FY2027 |
-3,89 €
-4,68 € – -3,10 €
|
0 | 2 |
| FY2026 |
-4,05 €
-5,08 € – -3,25 €
|
0 | 3 |
Points Clés
Negative free cash flow of -53,82M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current Ratio3,56
Interest Coverage0,00
Valorisation
P/E Ratio
-9,37
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -63,10M |
| ROE | N/A | ROA | -188,17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -53,82M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3,56 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,37 | P/B Ratio | N/A |
| P/S Ratio | N/A | PEG Ratio | 0,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 591,24M | Enterprise Value | 571,97M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 |
| Net Income | -63,10M | -6,28M | -14,35M |
| EPS (Diluted) | -17,83 | -1,77 | -4,05 |
| Gross Profit | 0,0 | 0,0 | 0,0 |
| Operating Income | -64,83M | -11,38M | -2,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 33,53M | 45,66M | 21,49M |
| Total Liabilities | 128,09M | 80,13M | 50,30M |
| Shareholders' Equity | -94,55M | -34,47M | -28,81M |
| Total Debt | 3,70M | 0,0 | 24,15M |
| Cash & Equivalents | 22,98M | 14,98M | 21,40M |
| Current Assets | 28,88M | 45,63M | 21,49M |
| Current Liabilities | 8,11M | 2,61M | 469 000,0 |